NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis

Cancer Immunology, Immunotherapy

Volumn 60, Issue 4, 2011, Pages 537-546

  Werneck, Miriam B F ^a   Vieira De Abreu, Adriana ^b   Chammas, Roger ^c   Viola, João P B ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; Melanoma B16F10; NFAT; Tumor microenvironment

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; IMMUNOCOMPETENT CELL; INOCULATION; LUNG METASTASIS; LUNG PARENCHYMA; MELANOMA; MELANOMA CELL; METASTASIS POTENTIAL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NFATC TRANSCRIPTION FACTORS; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 79953770234     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0964-4     Document Type: Article

References (40)

1. Balkwill F, Mantovani A (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87(4):401-406
2. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24-37 (Pubitemid 43053650)
3. Li J, Goldstein I, Glickman-Nir E, Jiang H, Chess L (2001) Induction of TCR Vbeta-specific CD8 + CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 167(7):3800-3808 (Pubitemid 32910825)
4. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39-51
5. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, De Caprio JA, Modiano JF, Burakoff SJ (2002) NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10(5):1071-1081 (Pubitemid 35453825)
6. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA, Viola JP (2002) NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J 16(14):1940-1942
7. Carvalho LD, Teixeira LK, Carrossini N, Caldeira AT, Ansel KM, Rao A, Viola JP (2007) The NFAT1 transcription factor is a repressor of cyclin A2 gene expression. Cell Cycle 6(14):1789-1795 (Pubitemid 47327933)
8. Viola JP, Carvalho LD, Fonseca BP, Teixeira LK (2005) NFAT transcription factors: from cell cycle to tumor development. Braz J Med Biol Res 38(3):335-344 (Pubitemid 40485172)
9. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP (2008) Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28(23):7168-7181
10. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V (2006) Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2 +/calcineurin signaling pathway. EMBO J 25(15):3714-3724 (Pubitemid 44264881)
11. Mancini M, Toker A (2009) NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 9(11):810-820
12. Marafioti T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TF, Du MQ, Leoncini L, Moller P, Natkunam Y, Siebert R, Mason DY (2005) The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol 128(3):333-342 (Pubitemid 40216155)
13. Medyouf H, Alcalde H, Berthier C, Guillemin MC, dos Santos NR, Janin A, Decaudin D, de The H, Ghysdael J (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 13 (6):736-741 (Pubitemid 46889757)
14. Neal JW, Clipstone NA (2002) Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J Biol Chem 277(51):49776-49781 (Pubitemid 36014424)
15. Pham LV, Tamayo AT, Yoshimura LC, Lin-Lee YC, Ford RJ (2005) Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106(12):3940-3947 (Pubitemid 41739035)
16. Kakuta S, Tagawa Y, Shibata S, Nanno M, Iwakura Y (2002) Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms. Immunology 105(1):92-100 (Pubitemid 34128044)
17. Rodrigues EG, Garofalo AS, Travassos LR (2002) Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo. Cytokines Cell Mol Ther 7(3):107-116 (Pubitemid 36850425)
18. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410(6832):1107-1111 (Pubitemid 32391043)
19. Kobayashi M, Kobayashi H, Pollard RB, Suzuki F (1998) A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 160(12):5869-5873 (Pubitemid 28298045)
20. Lynch DH, Namen AE, Miller RE (1991) In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol 21(12):2977-2985
21. Dobrzanski MJ, Reome JB, Dutton RW (2001) Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. J Immunol 167(1):424-434 (Pubitemid 32567808)
22. Kiani A, Garcia-Cozar FJ, Habermann I, Laforsch S, Aebischer T, Ehninger G, Rao A (2001) Regulation of interferon-gamma gene expression by nuclear factor of activated T cells. Blood 98(5):1480-1488
23. Rao A, Luo C, Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15:707-747 (Pubitemid 27169297)
24. Teixeira LK, Fonseca BP, Vieira-de-Abreu A, Barboza BA, Robbs BK, Bozza PT, Viola JP (2005) IFN-gamma production by CD8 + T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol 175(9):5931-5939 (Pubitemid 41508078)
25. Fonseca BP, Olsen PC, Coelho LP, Ferreira TP, Souza HS, Martins MA, Viola JP (2009) NFAT1 transcription factor regulates pulmonary allergic inflammation and airway responsiveness. Am J Respir Cell Mol Biol 40(1):66-75
26. Kiani A, Viola JP, Lichtman AH, Rao A (1997) Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity 7(6):849-860 (Pubitemid 28064898)
27. Viola JP, Kiani A, Bozza PT, Rao A (1998) Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. Blood 91(7):2223-2230 (Pubitemid 28155494)
28. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T, Rao A (1996) An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272(5263):892-895
29. Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, Rao A (1996) Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271(18):10884-10891 (Pubitemid 26145827)
30. Adler H, Beland JL, Kozlow W, Del-Pan NC, Kobzik L, Rimm IJ (1998) A role for transforming growth factor-beta1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection. Blood 92(7):2581-2589 (Pubitemid 28453003)
31. Spangrude GJ (1994) Biological and clinical aspects of hematopoietic stem cells. Annu Rev Med 45:93-104
32. Nilsson LM, Nilsson-Ohman J, Zetterqvist AV, Gomez MF (2008) Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys? Curr Opin Lipidol 19(5):483-490
33. Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserinedependent manner. Cancer Lett 283(2):168-175
34. Muller MR, Rao A (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10(9):645-656
35. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329-360 (Pubitemid 38680426)
36. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126(2):375-387 (Pubitemid 44092960)
37. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL (2010) Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 5(7):e11469
38. Stover DG, Bierie B, Moses HL (2007) A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 101(4):851-861 (Pubitemid 47040867)
39. Maxeiner JH, Karwot R, Sauer K, Scholtes P, Boross I, Koslowski M, Tureci O, Wiewrodt R, Neurath MF, Lehr HA, Finotto S (2009) A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8 + T lymphocytes. Cancer Res 69(7):3069-3076
40. Quezada SA, Peggs KS, Curran MA, Allison JP (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J Clin Invest 116(7):1935-1945 (Pubitemid 44033317)